IRD
Financials
- Market Capitalization 292.21 M
- Employee 28
- Founded 2018
- CEO N/A
- Website www.opusgtx.com
- Headquarter Delaware, United States
- FIGI BBG000BT34Q3
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3356 |  NMRA Neumora Therapeutics, Inc. - Common Stock | 1.60 USD | 0.00% | -13.04% | +72.04% | +24.03% | 296.45 M USD | ||
| 3361 |  INDP Indaptus Therapeutics, Inc. - Common Stock | 2.60 USD | -1.14% | -6.14% | -28.18% | +36.84% | 294.43 M USD | ||
| 3388 |  TTRX Turn Therapeutics Inc. - Common Stock | 9.52 USD | +0.53% | +9.80% | +54.05% | -4.80% | 283.58 M USD | ||
| 3389 |  MGNX MacroGenics, Inc. - Common Stock | 4.45 USD | -1.11% | -5.12% | +12.37% | +183.44% | 282.86 M USD |
Frequently asked questions about Opus Genetics, Inc. - Common Stock
What is the Opus Genetics, Inc. - Common Stock stock price today?
The current price of Opus Genetics, Inc. - Common Stock (IRD) is 3.59. Over the past 24 hours, the stock has changed by -5.77%. Follow the IRD chart for real-time price dynamics.
What is the stock ticker of Opus Genetics, Inc. - Common Stock?
Opus Genetics, Inc. - Common Stock trades under the ticker IRD. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Opus Genetics, Inc. - Common Stock stock going up?
IRD has changed by -12.65% over the last week, -12.86% over the last month, and -3.49% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Opus Genetics, Inc. - Common Stock net income for the last quarter?
Opus Genetics, Inc. - Common Stock reported net income of -65.53 M for the last quarter. The previous quarter showed -16.52 M, which means net income changed by -296.63%.
How many employees does Opus Genetics, Inc. - Common Stock have?
As of the latest available data, Opus Genetics, Inc. - Common Stock has 28 employees. Workforce size can provide additional context about the company's scale and operations.
What is Opus Genetics, Inc. - Common Stock EBITDA?
Opus Genetics, Inc. - Common Stock EBITDA is -14.35 M, and its EBITDA margin is -665.32%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Opus Genetics, Inc. - Common Stock stock?
You can buy Opus Genetics, Inc. - Common Stock (IRD) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Opus Genetics, Inc. - Common Stock stock?
Investing in Opus Genetics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IRD chart and related analysis on metatrader.com as part of your research.